Maite E Del Valle Rolon, MD

Dr. Robert A. Wood is a professor of pediatrics at the Johns Hopkins University School of Medicine and a professor of international health at the Johns Hopkins Bloomberg School of Public Health. An internationally recognized expert in food allergy and childhood asthma, Dr. Wood is chief of the Eudowood Division of Allergy and Immunology in the Johns Hopkins Children's Center. He also serves as director and attending physician of the Pediatric Allergy Clinics at The Johns Hopkins Hospital and as director of the Pediatric Allergy Consultation Service.Dr. Wood is an internationally recognized expert in food allergy and childhood asthma and has published more than 200 manuscripts in scientific journals, including The New England Journal of Medicine, JAMA, Pediatrics, and the Journal of Allergy and Clinical Immunology, as well as three books and numerous book chapters. He is associate editor of the Journal of Allergy and Clinical Immunology and deputy editor of the journal Pediatric Allergy and Immunology, and was previously an associate editor of the Annals of Allergy, Asthma, and Immunology. He has served on the board of directors of the American Board of Allergy and Immunology and the American Academy of Allergy Asthma and Immunology, where he is now secretary-treasurer and president-elect beginning in 2018.Dr. Wood earned his medical degree from the University of Rochester School of Medicine and Dentistry. He completed both a three-year pediatrics residency—serving as chief resident the final year—and a pediatric allergy and immunology fellowship at Johns Hopkins Hospital. Dr. Wood joined the Johns Hopkins faculty in 1988.

Dr. James Casella is a professor of pediatrics and oncology at the Johns Hopkins University School of Medicine. As the Johns Hopkins’ Rainey Professor of Pediatric Hematology, Dr. Casella is chief of the Division of Pediatric Hematology at Johns Hopkins Children's and director of the Basic and Translational Research Program in Sickle Cell Disease, Comprehensive Sickle Cell Center and the Maryland Hemophilia Treatment Center at Johns Hopkins.He supervises several labs investigating the cellular and molecular basis of pediatric blood-borne diseases. He is seeking to develop better treatments for sickle cell disease and the prevention of central nervous system complications of this disorder, including stroke.Dr. Casella received his undergraduate degree in mathematics from Union College. He earned his M.D. from SUNY of Syracuse and completed a residency in pediatrics at Johns Hopkins University School of Medicine, where he was subsequently a fellow in hematology/oncology. He has been a member of the Johns Hopkins’ faculty since 1983.A research scientist as well as a clinician, he co-directs the hematology/oncology fellowship program at Johns Hopkins Hospital and is an adjunct senior investigator (Pediatric Oncology Branch) in the Division of Clinical Sciences, National Cancer Institute, National Institutes of Health. He is also director of the NHLBI-funded K12 in benign hematology program at Johns Hopkins that trains young clinician/investigators in benign hematology and transfusion medicine.Dr. Casella has served on numerous university, hospital, and advisory committees, many geared toward hematology, pediatrics and transfusion. He has received many awards from the Johns Hopkins Hospital, including the Alexander "Buck" Schaffer Award for Outstanding Contribution to the Teaching of House Officers. He and a colleague created the Johns Hopkins/St. Agnes Comprehensive Hemophilia Clinic to improve care for patients with the disease.

Dr. Howard Lederman is a professor of pediatrics at the Johns Hopkins University School of Medicine. He is the director of the Immunodeficiency Clinic, the Pediatric Immunology Laboratory, and the Ataxia-Telangiectasia (A-T) Clinical Center. Dr. Lederman specializes in the evaluation, diagnostic testing and long-term management of patients of all ages who have known or suspected primary immunodeficiency diseases. He is an expert on the use of gamma globulin therapy for a wide variety of disorders. After receiving his M.D. and Ph.D. from the University of Michigan, Dr. Lederman came to Johns Hopkins Children’s Center for a residency in pediatrics, followed by a fellowship in immunology at the Hospital for Sick Children in Toronto. Dr. Lederman’s current research laboratory and clinical research focuses on better understanding and treating patients with ataxia-telangiectasia, a devastating neurological disorder for which there is no cure.He is a member of numerous professional societies, including American Association of Immunologists, the American Society for Microbiology and the Clinical Immunology Society.